Lv11
30 积分 2023-11-13 加入
Advancements in Bispecific Antibodies for Multiple Myeloma: What's New and What Lies Ahead
1小时前
待确认
Progression of disease within 6 months: revised early disease progression threshold for ENKTL
5天前
已完结
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial
7天前
已完结
Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma
1个月前
已完结
Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters
1个月前
已完结
Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis
1个月前
已完结
Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis
2个月前
已完结
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
2个月前
已完结
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
2个月前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
3个月前
已完结
皖公网安备34019202002308
